Boyles, Paul W., MD
FDA records disqualification of the clinical investigator Boyles, Paul W., MD on 13 Apr 1995.
Source evidence summary
What this FDA outcome means
FDA describes disqualification as loss of eligibility to receive investigational products and conduct covered clinical investigations. The linked decision establishes the grounds and scope; this entry does not describe a general medical-licence revocation.
Chronology in the published evidence
FDA initiated disqualification proceedings and offered an opportunity to explain (NIDPOE).
FDA offered an opportunity for a hearing (NOOH). This notice is not itself a final disqualification.
FDA recorded the outcome “Disqualified”.
- FDA status
- Disqualified
- Date of FDA status
- Recorded value
1995-04-13
Programs recorded by the publisher
- FDA clinical investigator proceedings
A matching name alone does not establish identity. Check the original publisher’s measures, dates and exceptions before deciding how this entry applies to a person, organization or asset.
Check your own customers or vendors.
Screen your clinical investigators against the FDA Clinical Investigator Disqualification Proceedings and other available sources with SanctionsKit.
Compare names, aliases and dates of birth where available. Review possible matches and save the evidence.
250 free live checks. No card needed. Share them across the API and dashboard. Your first workspace gets them once, with no monthly reset. Choose a paid plan for more.
Cite, download or correct this record
Cite or save this record
View citation text
Boyles, Paul W., MD. United States Food and Drug Administration: Clinical Investigators—Disqualification Proceedings. Official source: https://www.accessdata.fda.gov/scripts/SDA/sdDetailNavigation.cfm?id=CD5EDDB44CA4AA37E040A8C0754D57E1&sd=clinicalinvestigatorsdisqualificationproceedings SanctionsKit: https://www.sanctionskit.com/records/us-fda-restricted/boyles-paul-w-md--id-Q0Q1RUREQjQ0Q0E0QUEzN0UwNDBBOEMwNzU0RDU3RTE Source version: us-fda-restricted:1.0.0:63611f4f6595671d29a47db422ac9b490b2e935b4c4e782d39673dda8fdcb5b9. Retrieved: 2026-11-01T19:51:22.442Z. Last checked: 2026-11-01T19:51:22.442Z. This cites one source record. Check the official source for what the listing covers and when it applies.
This is a current view and may change. The citation and CSV name the source version you read.
Report a correction with the record link and the official source that supports it. Help for journalists and researchers.
Source context and scope
Status as described by the source
- Current restriction matching
- FDA reports disqualification
Scope and limitations
- Status scope
- FDA disqualification from receiving investigational products and conducting covered clinical investigations; verify the current FDA decision.
Further source details
- Record type
- FDA clinical investigator disqualification proceeding
- FDA center
- CDER
- Date NIDPOE Issued
- Recorded value
1990-07-10 - Date NOOH Issued
- Recorded value
1991-04-26 - Date of Presiding Officer Report
- 1993-02-16
- Date of Commissioner's Decision
- 1995-04-13
Continue reviewing this source.
Compare the original evidence and explore other records in FDA Clinical Investigator Disqualification Proceedings.